Nadya Vinsdata BS , R. Eric Heidel PhD , Paul J. Hauptman MD
{"title":"Online Marketing of Alternative Medicine for Heart Failure: An Assessment of Amazon.com","authors":"Nadya Vinsdata BS , R. Eric Heidel PhD , Paul J. Hauptman MD","doi":"10.1016/j.amjmed.2024.12.016","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>A wide array of products in the category of complementary or alternative medicine for cardiovascular disease and prevention are readily available on online retail platforms. However, a critical assessment of these products, including their therapeutic claims, has not been previously performed.</div></div><div><h3>Methods</h3><div>“Heart failure supplement” and similar terms were entered into the Amazon.com search engine, and all medication products including claims, content, and formulations were individually evaluated.</div></div><div><h3>Results</h3><div>We identified 111 products, most of which lacked safety information. They included, on average, 8.2 ingredients. The median cost per order was $27.60. The majority were in capsule form (58.6%), and the most common ingredient was coenzyme Q10. All included a legal disclaimer. Physician testimonials were included in only 3 product listings.</div></div><div><h3>Conclusions</h3><div>Given the popularity of complementary and alternative medicine and their easy accessibility through online retailing, and the fact that prior studies suggest a minority of patients discuss use with their providers, further study is needed to evaluate the extent of and the potential for both undiagnosed drug-drug interactions and replacement of guideline-directed medical treatment for heart failure with unapproved products.</div></div>","PeriodicalId":50807,"journal":{"name":"American Journal of Medicine","volume":"138 4","pages":"Pages 750-752"},"PeriodicalIF":5.3000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002934324008441","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background
A wide array of products in the category of complementary or alternative medicine for cardiovascular disease and prevention are readily available on online retail platforms. However, a critical assessment of these products, including their therapeutic claims, has not been previously performed.
Methods
“Heart failure supplement” and similar terms were entered into the Amazon.com search engine, and all medication products including claims, content, and formulations were individually evaluated.
Results
We identified 111 products, most of which lacked safety information. They included, on average, 8.2 ingredients. The median cost per order was $27.60. The majority were in capsule form (58.6%), and the most common ingredient was coenzyme Q10. All included a legal disclaimer. Physician testimonials were included in only 3 product listings.
Conclusions
Given the popularity of complementary and alternative medicine and their easy accessibility through online retailing, and the fact that prior studies suggest a minority of patients discuss use with their providers, further study is needed to evaluate the extent of and the potential for both undiagnosed drug-drug interactions and replacement of guideline-directed medical treatment for heart failure with unapproved products.
期刊介绍：
The American Journal of Medicine - "The Green Journal" - publishes original clinical research of interest to physicians in internal medicine, both in academia and community-based practice. AJM is the official journal of the Alliance for Academic Internal Medicine, a prestigious group comprising internal medicine department chairs at more than 125 medical schools across the U.S. Each issue carries useful reviews as well as seminal articles of immediate interest to the practicing physician, including peer-reviewed, original scientific studies that have direct clinical significance and position papers on health care issues, medical education, and public policy.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
